Synthesis of fluorescent biochemical tools related to the 2-azetidinone class of cholesterol absorption inhibitors.

[1]  C. Farley,et al.  Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663 , 2000, British journal of pharmacology.

[2]  D. Burnett,et al.  An enzymatic synthesis of glucuronides of azetidinone-based cholesterol absorption inhibitors. , 1999, Bioorganic & medicinal chemistry.

[3]  J. Clader,et al.  Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4 -hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption. , 1998, Journal of medicinal chemistry.

[4]  H. Davis,et al.  Sugar-substituted 2-azetidinone cholesterol absorption inhibitors: enhanced potency by modification of the sugar. , 1998, Bioorganic & medicinal chemistry letters.

[5]  H. Davis,et al.  Sugar-substituted 2-azetidinones as cholesterol absorption inhibitors. , 1998, Bioorganic & medicinal chemistry letters.

[6]  H. Davis,et al.  In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. , 1997, The Journal of pharmacology and experimental therapeutics.

[7]  R. Burrier,et al.  2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus. , 1996, Journal of medicinal chemistry.

[8]  J. Clader,et al.  Metabolism and structure activity data based drug design: discovery of (−) SCH 53079 an analog of the potent cholesterol absorption inhibitor (−) SCH 48461 , 1996 .

[9]  R. Burrier,et al.  Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461. , 1995, Atherosclerosis.

[10]  J. Clader,et al.  Trans diastereoselective synthesis of 3-alkyl substituted β-lactams via the acid chloride-imine reaction of nonactivated acid chlorides , 1995 .

[11]  R. Burrier,et al.  2-Azetidinones as inhibitors of cholesterol absorption. , 1994, Journal of medicinal chemistry.

[12]  S. G. Wood,et al.  Solvent, not palladium oxidation state, is the primary determinant for successful coupling of terminal alkynes with iodo-nucleosides , 1990 .

[13]  Y. Tohda,et al.  A convenient synthesis of acetylenes: catalytic substitutions of acetylenic hydrogen with bromoalkenes, iodoarenes and bromopyridines , 1975 .